Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
dermal filler
|
| gptkbp:administeredBy |
medical professionals
|
| gptkbp:approvedBy |
gptkb:United_Kingdom
|
| gptkbp:contains |
hyaluronic acid
|
| gptkbp:cross-linking_agent |
BDDE
|
| gptkbp:duration_of_effect |
6-18 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Revolax
|
| gptkbp:manufacturer |
Across Co. Ltd.
|
| gptkbp:marketedIn |
gptkb:Europe
|
| gptkbp:not_approved_by |
gptkb:FDA_(United_States)
|
| gptkbp:origin |
gptkb:South_Korea
|
| gptkbp:type |
injectable gel
|
| gptkbp:usedFor |
lip augmentation
cheek enhancement facial aesthetic treatments nasolabial fold correction |
| gptkbp:bfsParent |
gptkb:Life_Regiment_Hussars
|
| gptkbp:bfsLayer |
8
|